Barely Significant
← all excerpts

COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort.

Sci Adv · 2024 · PMC11168476 · PMID 38865463

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Analysis of T cell response by COVID-Score before (T2a and T2b) and after the third booster dose (T3) showed a trend consistent with previous reports ( 41 – 43 ) that showed the contraction following two-dose of mRNA vaccine and expansion after the third booster dose ( Fig. 6A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.